Efficacy and Safety of Empagliflozin in GSD-Ib Patients

NCT05960617 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Glycogen Storage Disease Type IB

Interventions

DRUG: Empagliflozin

Sponsor

Xinhua Hospital, Shanghai Jiao Tong University School of Medicine